A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/26/2002	US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485900 Synthetic antigen for the detection of AIDS-related disease
11/26/2002	US6485899 Anti-bacterial methods and materials
11/26/2002	US6485729 An anti-influenza vaccine, wherein the improvement comprises having as an additive a substantially pure, influenza neuraminidase and influenza hemagglutinin protein
11/26/2002	US6485728 Mimicing the conformational neutralizing epitopes on papilloma virions
11/26/2002	US6485726 Transepithelial delivery of antigens to provoke tolerance and immunity; the delivery of therapeutics conjugated to a fcrn binding partner to epithelium
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/26/2002	CA2067184C New linker for bioactive agents
11/26/2002	CA1341403C Recombinant a vipox virus
11/23/2002	CA2382443A1 Use of anti-ctla-4 antibodies
11/22/2002	CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002	WO2002092854A2 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092818A2 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
11/21/2002	WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002	WO2002092791A1 Tissues or organs for use in xenotransplantation
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092786A2 A helper dependent adenoviral vector system and methods for using the same
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092635A2 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
11/21/2002	WO2002092632A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002	WO2002092628A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
11/21/2002	WO2002092627A2 Use of casb 7439 for treatment and diagnosis of lung cancer
11/21/2002	WO2002092626A2 Cleavage and polyadenylation complex of precursor mrna
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092554A1 Complexes for transferring substances of interest into a cell
11/21/2002	WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	WO2002092132A2 Microparticles and methods for delivery of recombinant viral vaccines
11/21/2002	WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	WO2002092127A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	WO2002092126A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/21/2002	WO2002092125A1 Compositions for use in treating ige-associated disorders
11/21/2002	WO2002092054A2 Immune modulation device for use in animals
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092012A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002	WO2002092011A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092001A2 Compositions and methods for the therapy and diagnosis of lung cancer
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091998A2 Novel meningitis conjugate vaccine
11/21/2002	WO2002091996A2 Methods for treating cancer
11/21/2002	WO2002091969A1 Treating epidermlyosis bullosa with thymosin beta 4
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002072845A3 Salmonella promoter for heterologous gene expression
11/21/2002	WO2002072798A9 Fas ligand-expressing hematopoietic cells for transplantation
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002052014A3 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173625 Hybrid polypeptide for use in the treatment and prevention of allergic disorders
11/21/2002	US20020173476 Cancer diagnosis
11/21/2002	US20020173462 Fibrinogen binding protein
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172985 Cassette for expressing a Toxoplasma gondii P30 protein
11/21/2002	US20020172976 P. gingivalis polynucleotides and uses thereof
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172728 Administering to the woman an effective amount of an herbal extract wherein an active ingredient in herbal extract is galanthamine for improving estrogen-deficiency related neurodegeneration and cognitive dysfunction
11/21/2002	US20020172717 Instilling microparticle or nanoparticle comprising biocompatible polymer and therapeutic agent into a patient's bladder such that portion of instilled microparticle or nanoparticles are localized to lymph nodes; releasing
11/21/2002	US20020172692 Vaccine composition against malaria
11/21/2002	US20020172691 Use of a bacterial vaccinating preparation developed from a given bacterium of Bordetella genus for the preparation of protective antigen for man and animals against infections and toxic effects caused by bacterium of Bordetella genus
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172689 Providing a naked virus having a capsid; covalently bonding a linker molecule to capsid, wherein polymer is covalently attached to the linker molecule to form a polymer-protected virus for forming viral-physiological structure
11/21/2002	US20020172688 HLA-restricted cytotoxic T-Lymphocytevaccine for prevention of HIV infection
11/21/2002	US20020172687 Anti-Viral Treatment With Pertussis Toxin B Oligomer
11/21/2002	US20020172685 For therapy of mycobacterial disease is selected from the group consisting of tuberculosis and Crohn's disease; vaccines
11/21/2002	US20020172684 Useful in therapy, diagnosis, and prophylaxis of tuberculosis; vaccines
11/21/2002	US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds
11/21/2002	US20020172682 Using heat shock proteins to increase immune response
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	US20020172677 Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth

1 ... 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 ... 1823